A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.

Erectile dysfunction (ED) impacts an estimated 18 million men in the U.S. alone, yet it is rarely discussed openly. John Smith, DO, a urologist at University of Utah Health, addresses the barriers to ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

GLP-1 weight loss drugs may increase erectile dysfunction risk in men with Type 2 diabetes, but experts say evidence is ...

A recent issue of Sexual Medicine Reviews includes an extensive field review on post-SSRI sexual dysfunction (PSSD), a medical condition tied to stopping SSRI and SNRI antidepressants that was ...

Almost half of Australian men will experience erectile dysfunction, but it's not something that's easy to talk about — or even acknowledge. Matt Tilley, a clinical psychologist and lecturer in ...